Efficacy and safety of transvenous atrial cardioversion in patients with mitral valve disease and long-standing atrial fibrillation

PACE - Pacing and Clinical Electrophysiology

Volumn 23, Issue 11 II, 2000, Pages 1894-1897

  Gronefeld, G C ^a   Li, Y G ^a   Bogun, F ^a   Hohnloser, S H ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Amiodarone; Atrial fibrillation; Internal cardioversion; Mitral valve disease

Indexed keywords

AMIODARONE;

ADULT; AGED; CARDIOVERSION; CLINICAL ARTICLE; CONFERENCE PAPER; CORONARY SINUS; DEFIBRILLATION; DISEASE DURATION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTHYROIDISM; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; SINUS RHYTHM;

EID: 0033670854     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2000.tb07047.x     Document Type: Conference Paper

References (17)

1. New method for terminating cardiac arrhythmias
2. Optimal technique for electrical cardioversion of atrial fibrillation
3. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter
4. Clinical competence in elective direct current (DC) cardioversion
5. Electrical reversion of cardiac arrhythmias
6. High energy transcatheter cardioversion of chronic atrial fibrillation
7. Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations
8. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans
9. Multicenter results of TADpole heart wire system used to treat postoperative atrial fibrillation
10. Effect of electrode position on outcome of low-energy intracardiac cardioversion of atrial fibrillation
11. Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation
12. Internal atrial defibrillation in humans. Improved efficacy of biphasic waveforms and the importance of phase duration
13. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation
14. Low energy transvenous cardioversion of short duration atrial tachyarrhythmias in humans using a single lead system
15. Low energy internal atrial cardioversion in atrial fibrillation lasting more than a year
16. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators
17. Long-term outcome in patients with chronic atrial fibrillation after successful internal cardioversion